Sorafenib in Relapsed AML With FMS-Like Receptor Tyrosine Kinase-3 Internal Tandem Duplication Mutation

Journal article

Peer reviewed

S. Giri, Shadi Hamdeh, V. R. Bhatt and J. K. Schwarz

Journal of the National Comprehensive Cancer Network, Vol.13(5), pp.508-514

05/2015

PMID: 25964636

Metrics

4 Record Views

Title: Sorafenib in Relapsed AML With FMS-Like Receptor Tyrosine Kinase-3 Internal Tandem Duplication Mutation
Creators: S. Giri (Author)
Shadi Hamdeh (Author) - Creighton University
V. R. Bhatt (Author)
J. K. Schwarz (Author)
Publication Details: Journal of the National Comprehensive Cancer Network, Vol.13(5), pp.508-514
Publisher: by the National Comprehensive Cancer Network
Number of pages: 508-514
Identifiers: 991005932309102656
Academic Unit: School of Medicine; Internal Medicine
Language: English
Resource Type: Journal article